Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (148 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Apr 2017 – 20 Aug 2026, limited by Quantum Gold ETF FOF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Quantum Gold ETF FOF | Gold |
|---|---|---|
| 01 Apr 2017 | ₹100.00 | ₹100.00 |
| 12 Jan 2018 | ₹101.84 | ₹102.50 |
| 24 Oct 2018 | ₹107.87 | ₹108.50 |
| 06 Aug 2019 | ₹122.53 | ₹123.13 |
| 18 May 2020 | ₹160.38 | ₹162.81 |
| 27 Feb 2021 | ₹151.99 | ₹154.05 |
| 10 Dec 2021 | ₹155.87 | ₹157.95 |
| 22 Sep 2022 | ₹161.89 | ₹164.53 |
| 04 Jul 2023 | ₹187.62 | ₹190.90 |
| 15 Apr 2024 | ₹229.99 | ₹234.34 |
| 26 Jan 2025 | ₹253.98 | ₹259.37 |
| 07 Nov 2025 | ₹374.12 | ₹382.49 |
| 20 Aug 2026 | ₹485.87 | ₹493.25 |
| Metric | Quantum · Regular NAV ₹59.14 High risk ★★★★☆ | Category median FoF Domestic · 148 funds |
|---|---|---|
| +58.02% | +7.03% | |
| +37.39% | +13.88% | |
| +25.76% | +11.19% | |
| — | +11.61% | |
| +18.34% | +10.54% | |
| +32.87% | — | |
| +16.80% | +12.35% | |
| +15.05% | +10.37% | |
| — | +8.94% | |
| Risk | ||
| 21.22% | 15.84% | |
| 1.46 | 0.70 | |
| 2.07 | 0.97 | |
| -24.58% | -19.67% | |
| Gold | — | |
| -0.09% | +1.35% | |
| 1.00 | 0.94 | |
| 100.4% | 97.2% | |
| 101.2% | 93.6% | |
| 0.51% | 0.58% | |
| ₹516.64Cr | ₹226.32Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 12% | 10% | |
| Chirag Mehta | — | |
| 01 Apr 2017 | — | |
| — | — | |
| — | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.